CONMED CORP (CNMD) Stock Fundamental Analysis
USA - NYSE:CNMD - US2074101013 - Common Stock
47.825 USD
+0.07 (+0.14%)
CNMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. While CNMD belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CNMD is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
CNMD had positive earnings in the past year.
In the past year CNMD had a positive cash flow from operations.
CNMD had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CNMD had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 4.73%, CNMD belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
CNMD has a better Return On Equity (10.99%) than 86.77% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.55%, CNMD belongs to the top of the industry, outperforming 83.60% of the companies in the same industry.
CNMD had an Average Return On Invested Capital over the past 3 years of 5.34%. This is below the industry average of 9.00%.
The 3 year average ROIC (5.34%) for CNMD is below the current ROIC(7.55%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROIC | 7.55% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
Looking at the Profit Margin, with a value of 8.31%, CNMD belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
CNMD's Profit Margin has improved in the last couple of years.
CNMD's Operating Margin of 14.38% is amongst the best of the industry. CNMD outperforms 83.07% of its industry peers.
CNMD's Operating Margin has improved in the last couple of years.
CNMD's Gross Margin of 56.05% is in line compared to the rest of the industry. CNMD outperforms 52.38% of its industry peers.
In the last couple of years the Gross Margin of CNMD has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CNMD is creating some value.
The number of shares outstanding for CNMD has been increased compared to 1 year ago.
The number of shares outstanding for CNMD has been increased compared to 5 years ago.
The debt/assets ratio for CNMD has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.04 indicates that CNMD is not a great score, but indicates only limited risk for bankruptcy at the moment.
CNMD has a Altman-Z score (2.04) which is in line with its industry peers.
CNMD has a debt to FCF ratio of 5.95. This is a neutral value as CNMD would need 5.95 years to pay back of all of its debts.
The Debt to FCF ratio of CNMD (5.95) is better than 78.31% of its industry peers.
A Debt/Equity ratio of 0.88 indicates that CNMD is somewhat dependend on debt financing.
CNMD has a Debt to Equity ratio of 0.88. This is in the lower half of the industry: CNMD underperforms 74.60% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Altman-Z | 2.04 |
ROIC/WACC1.18
WACC6.38%
2.3 Liquidity
A Current Ratio of 2.23 indicates that CNMD has no problem at all paying its short term obligations.
CNMD has a Current ratio (2.23) which is in line with its industry peers.
A Quick Ratio of 1.00 indicates that CNMD should not have too much problems paying its short term obligations.
CNMD has a worse Quick ratio (1.00) than 75.66% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.38%, which is quite impressive.
CNMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 9.44% yearly.
Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 3.94% in the last year.
The Revenue has been growing slightly by 6.47% on average over the past years.
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
3.2 Future
CNMD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.42% yearly.
The Revenue is expected to grow by 5.42% on average over the next years.
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
CNMD is valuated reasonably with a Price/Earnings ratio of 10.65.
CNMD's Price/Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 93.12% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.89. CNMD is valued rather cheaply when compared to this.
With a Price/Forward Earnings ratio of 9.83, the valuation of CNMD can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 94.18% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.65 | ||
| Fwd PE | 9.83 |
4.2 Price Multiples
92.59% of the companies in the same industry are more expensive than CNMD, based on the Enterprise Value to EBITDA ratio.
96.30% of the companies in the same industry are more expensive than CNMD, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.98 | ||
| EV/EBITDA | 8.82 |
4.3 Compensation for Growth
CNMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of CNMD may justify a higher PE ratio.
PEG (NY)1.11
PEG (5Y)1.13
EPS Next 2Y8.14%
EPS Next 3Y9.42%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.66%.
CNMD's Dividend Yield is rather good when compared to the industry average which is at 1.79. CNMD pays more dividend than 95.24% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.31, CNMD is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.66% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
22.42% of the earnings are spent on dividend by CNMD. This is a low number and sustainable payout ratio.
DP22.42%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
NYSE:CNMD (10/27/2025, 10:51:03 AM)
47.825
+0.07 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners114.95%
Inst Owner Change1.26%
Ins Owners0.27%
Ins Owner Change-0.53%
Market Cap1.48B
Revenue(TTM)1.33B
Net Income(TTM)110.20M
Analysts73.33
Price Target62.99 (31.71%)
Short Float %6.82%
Short Ratio5.91
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.66% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP22.42%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)0.37%
Max EPS beat(2)14.78%
EPS beat(4)4
Avg EPS beat(4)7%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.79%
EPS beat(12)10
Avg EPS beat(12)-0.43%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)1
Avg Revenue beat(2)-0.12%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)0%
PT rev (3m)-10.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)5.71%
EPS NY rev (1m)0%
EPS NY rev (3m)1.69%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.04%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.65 | ||
| Fwd PE | 9.83 | ||
| P/S | 1.12 | ||
| P/FCF | 9.98 | ||
| P/OCF | 8.96 | ||
| P/B | 1.48 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.82 |
EPS(TTM)4.49
EY9.39%
EPS(NY)4.87
Fwd EY10.17%
FCF(TTM)4.79
FCFY10.02%
OCF(TTM)5.34
OCFY11.16%
SpS42.85
BVpS32.4
TBVpS-13.11
PEG (NY)1.11
PEG (5Y)1.13
Graham Number57.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROCE | 9.38% | ||
| ROIC | 7.55% | ||
| ROICexc | 7.68% | ||
| ROICexgc | 25.98% | ||
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% | ||
| FCFM | 11.18% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexgc growth 3Y14.62%
ROICexgc growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 23.31% | ||
| Cap/Sales | 1.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.68% | ||
| Profit Quality | 134.53% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.04 |
F-Score7
WACC6.38%
ROIC/WACC1.18
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y11.97%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year45.54%
EBIT Next 3Y17.93%
EBIT Next 5YN/A
FCF growth 1Y832.34%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y345.31%
OCF growth 3Y14.3%
OCF growth 5Y11.92%
CONMED CORP / CNMD FAQ
What is the ChartMill fundamental rating of CONMED CORP (CNMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to CNMD.
What is the valuation status of CONMED CORP (CNMD) stock?
ChartMill assigns a valuation rating of 8 / 10 to CONMED CORP (CNMD). This can be considered as Undervalued.
How profitable is CONMED CORP (CNMD) stock?
CONMED CORP (CNMD) has a profitability rating of 8 / 10.
What is the valuation of CONMED CORP based on its PE and PB ratios?
The Price/Earnings (PE) ratio for CONMED CORP (CNMD) is 10.65 and the Price/Book (PB) ratio is 1.48.
How financially healthy is CONMED CORP?
The financial health rating of CONMED CORP (CNMD) is 4 / 10.